US 11,904,138 B2
Glucose level management without carbohydrate counting
Boyi Jiang, Pasadena, CA (US); Yuxiang Zhong, Arcadia, CA (US); Pratik J. Agrawal, Porter Ranch, CA (US); and Ali Dianaty, Porter Ranch, CA (US)
Assigned to Medtronic MiniMed, Inc., Northridge, CA (US)
Filed by Medtronic MiniMed, Inc., Northridge, CA (US)
Filed on Jan. 29, 2021, as Appl. No. 17/162,042.
Prior Publication US 2022/0241500 A1, Aug. 4, 2022
Int. Cl. A61M 5/172 (2006.01); G16H 50/20 (2018.01); G16H 20/60 (2018.01); A61K 9/00 (2006.01); A61K 38/28 (2006.01)
CPC A61M 5/1723 (2013.01) [A61K 9/0009 (2013.01); A61K 9/0019 (2013.01); A61K 38/28 (2013.01); G16H 20/60 (2018.01); G16H 50/20 (2018.01); A61M 2205/52 (2013.01); A61M 2230/201 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A system for glucose level management without carbohydrate counting, the system comprising:
one or more processors; and
one or more processor-readable storage media storing instructions which, when executed by the one or more processors, cause performance of:
obtaining contextual information for a meal;
predicting amounts of glucose to be absorbed into a bloodstream of a patient over a duration of time due to consumption of the meal based at least in part on a correlation between the contextual information for the meal and amounts of glucose absorbed into the bloodstream due to the consumption of the meal;
determining one or more amounts of insulin to counteract effects of the predicted amounts of glucose; and
affecting insulin therapy based on outputting information indicative of the determined one or more amounts of insulin.